Non-steroidal anti-inflammatory drugs for the prevention and treatment of cancer.
about
Anti-inflammatory/antioxidant use in long-term maintenance cancer therapy: a new therapeutic approach to disease progression and recurrenceGenetic polymorphisms in the cyclooxygenase-2 gene, use of nonsteroidal anti-inflammatory drugs, and breast cancer riskHiding in plain view: the potential for commonly used drugs to reduce breast cancer mortality.Polymorphisms in regulatory regions of cyclooxygenase-2 gene and breast cancer risk in Brazilians: a case-control studyCombination of physical activity, nutrition, or other metabolic factors and vaccine responseRoles for inflammation and regulatory T cells in colon cancer.Cancer inflammation and regulatory T cells.Knockout of the Bcmo1 gene results in an inflammatory response in female lung, which is suppressed by dietary beta-carotene.Dietary intake of pterostilbene, a constituent of blueberries, inhibits the beta-catenin/p65 downstream signaling pathway and colon carcinogenesis in ratsA ceramide analog inhibits cPLA(2) activity and consequent PGE(2) formation in LPS-stimulated macrophages.Risk of cancer among rheumatoid arthritis patients in California.Combination of atorvastatin with sulindac or naproxen profoundly inhibits colonic adenocarcinomas by suppressing the p65/β-catenin/cyclin D1 signaling pathway in rats.The EP1 receptor for prostaglandin E2 promotes the development and progression of malignant murine skin tumorsAdenovirus type 5 E1A-induced apoptosis in COX-2-overexpressing breast cancer cells.Does cytomegalovirus play a causative role in the development of various inflammatory diseases and cancer?More than structural cells, fibroblasts create and orchestrate the tumor microenvironment.Chemopreventive effects of celecoxib are limited to hormonally responsive mammary carcinomas in the neu-induced retroviral rat modelNon-steroidal anti-inflammatory drug and aspirin use and the risk of head and neck cancerIs it time for a new paradigm for systemic cancer treatment? Lessons from a century of cancer chemotherapyEffect of phenytoin on celecoxib pharmacokinetics in patients with glioblastoma.Regulation of the prostaglandin pathway during development of invasive bladder cancer in miceFreund's vaccine adjuvant promotes Her2/neu breast cancer.Role of COX-2 in epithelial-stromal cell interactions and progression of ductal carcinoma in situ of the breast.Role of the prostaglandin pathway and the use of NSAIDs in genitourinary malignancies.Anti-inflammatory action of pterostilbene is mediated through the p38 mitogen-activated protein kinase pathway in colon cancer cells.Bilharzial vs non-bilharzial related bladder cancer: pathological characteristics and value of cyclooxygenase-2 expression.Non-steroidal anti-inflammatory drugs and the risk of head and neck cancer: A case-control analysis.Licofelone-nitric oxide donors as anticancer agents.3-Phosphoinositide-dependent protein kinase-1/Akt signalling and inhibition in a canine prostate carcinoma cell line.Effect of prenatal exposure to diclofenac sodium on the male rat arteries: a stereological and histopathological study.Organ specificity of beta-carotene induced lung gene-expression changes in Bcmo1-/- mice.Systemic Immune-inflammation Index Predicts Survival of Patients After Curative Resection for Non-small Cell Lung Cancer.Enzyme Prodrug Therapy Engineered into Biomaterials
P2860
Q27010314-D055870E-1A09-44E6-9ACD-F20623AD665FQ28213217-C874BC40-A3ED-4748-8BBD-61FF413A64B5Q33739341-C07B0969-B2A6-416D-ADA0-5FEA78348398Q33741123-734F1E7C-FEA7-4333-96EF-FA7F13F41DE2Q33751144-5617649C-D26E-4BDC-8605-FA24D7E496F3Q33796554-FE036FEB-5D74-44A8-9E50-A78FD4A2F908Q33796582-CC0FAF2E-9E9B-4B42-960E-AB4B81279824Q33880194-3752BBE6-613C-4F76-940F-E0B3709E0AA3Q33974480-FFB5B915-F88C-429F-95AF-A43FBDF626CDQ34520481-9A31DA5E-7F54-4CF5-BD2C-00FFBF743531Q35162890-5FDEBD81-FB2B-4E9E-ACF6-76126AF62F75Q35522954-43FE82D4-3024-41E4-B602-79C91B24B27CQ35722400-6183BDE5-DFDA-4112-A938-D7A678D45E80Q36393246-65D8695C-6E0A-4C47-834D-DAF9D53007A3Q36395715-75AD63CF-5F5F-4F8E-99F5-30E7DBED2A1AQ36568993-34636D7A-7DBB-4CCC-B834-A739755CD348Q36643107-B0477AA0-0369-47D1-809C-E61CDAA2B7D0Q36746813-67297E73-FC9F-4DF1-AA58-EC847467F7CFQ36952188-9DFF916C-86E1-4B70-A52B-9429740EBDEAQ37036925-AC836130-BD03-4C45-8F6B-CFBDADC5163AQ37041680-4AAD4042-2519-4C0D-87EA-59E2601430D4Q37078499-C60A4383-75C7-4974-88C2-84C71E780B93Q37097204-93772588-1432-4121-AC3B-3D50368F66B9Q37202773-BD9A5266-544E-44F3-8D2C-D281D86577ECQ37366210-34EEBE12-0B37-4216-BD78-33156A44EDC2Q38413564-6FC89300-6C02-4ED9-BC99-AEC7612D8E62Q38414751-6C4E5936-134C-42AF-BF8F-72E717C860D3Q39522892-12FADB7B-8245-46E7-BC65-D515327C618BQ40165886-B91A22EC-0053-410D-98CA-B885B5A5F860Q45842796-00C33242-8157-4761-A281-D79E8BB9D129Q46454893-E4126BC3-B4AE-44FC-B11E-48AA2EFF3477Q52562926-C6374AA8-427D-4F01-8015-94972C7E34D4Q56769203-2B0F6BC2-BB97-4667-B089-F2B23A48BA96
P2860
Non-steroidal anti-inflammatory drugs for the prevention and treatment of cancer.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Non-steroidal anti-inflammatory drugs for the prevention and treatment of cancer.
@ast
Non-steroidal anti-inflammatory drugs for the prevention and treatment of cancer.
@en
type
label
Non-steroidal anti-inflammatory drugs for the prevention and treatment of cancer.
@ast
Non-steroidal anti-inflammatory drugs for the prevention and treatment of cancer.
@en
prefLabel
Non-steroidal anti-inflammatory drugs for the prevention and treatment of cancer.
@ast
Non-steroidal anti-inflammatory drugs for the prevention and treatment of cancer.
@en
P2860
P1476
Non-steroidal anti-inflammatory drugs for the prevention and treatment of cancer.
@en
P2093
P2860
P304
P356
10.1111/J.1365-2796.2005.01519.X
P407
P577
2005-08-01T00:00:00Z